Europe Travel Vaccines Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Analysis – by Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, and Others) and Application (Domestic Travel and Outbound Travel)

No. of Pages: 132    |    Report Code: BMIRE00025498    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Travel Vaccines Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Travel Vaccines Market – By Product

1.3.2        Europe Travel Vaccines Market – By Application

1.3.3        Europe Travel Vaccines Market – By Country

2.           Europe Travel Vaccines Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Travel Vaccines Market– Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Expert Opinion

5.           Europe Travel Vaccines Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Significant Rise in Travel and Tourism

5.1.2        Growing Incidences of Infectious Diseases

5.2         Market Restraints

5.2.1        High Cost of Travel Vaccines

5.3         Market Opportunities

5.3.1        Awareness Regarding Vaccines

5.4         Future Trends

5.4.1        Significant Demand for Vaccines

5.5         Impact Analysis

6.           Travel Vaccines Market – Europe Analysis

6.1         Europe Travel Vaccines Marker Revenue Forecast and Analysis

7.           Europe Travel Vaccines Market Analysis – By Product

7.1         Overview

7.2         Europe Travel Vaccines Market Revenue Share, by Product (2021 and 2028)

7.3         Hepatitis A

7.3.1        Overview

7.3.2        Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.4         Hepatitis B

7.4.1        Overview

7.4.2        Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.5         Meningococcal Vaccines

7.5.1        Overview

7.5.2        Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

8.           Europe Travel Vaccines Market Analysis – By Application

8.1         Overview

8.2         Europe Travel Vaccines Market Revenue Share, by Application (2021 and 2028)

8.3         Domestic Travel

8.3.1        Overview

8.3.2        Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

8.4         Outbound Travel

8.4.1        Overview

8.4.2        Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

9.           Europe Travel Vaccines Market – Country Analysis

9.1         Overview

9.1.1        Europe: Travel Vaccines Market, by Country, 2020 & 2028 (%)

9.1.1.1          UK: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.1.1          UK: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.1.2          UK: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.1.3          UK: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.2          Germany: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.2.1          Germany: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.2.2          Germany: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.2.3          Germany: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.3          France: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.3.1          France: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.3.2          France: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.3.3          France: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.4          Italy: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.4.1          Italy: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.4.2          Italy: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.4.3          Italy: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.5          Spain: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.5.1          Spain: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.5.2          Spain: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.5.3          Spain: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.6          Rest of Europe: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.6.1          Rest of Europe: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.6.2          Rest of Europe: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.6.3          Rest of Europe: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

10.        Travel Vaccines Market–Industry Landscape

10.1      Overview

10.2      Growth Strategies in the Travel Vaccines Market, (%)

10.3      Organic Developments

10.3.1     Overview

10.4      Inorganic Developments

10.4.1     Overview

11.        Company Profiles

11.1      GlaxoSmithKline plc.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Merck & Co., Inc.

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Sanofi

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Novartis AG

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Pfizer Inc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Dynavax Technologies

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Emergent BioSolutions Inc.

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      Abbott

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      Valneva SE.

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

12.        Appendix

12.1      About the Insight Partners

12.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             UK: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2.             UK: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3.             Germany: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4.             Germany: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5.             France: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6.             France: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7.             Italy: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8.             Italy: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9.             Spain: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10.          Spain: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11.          Rest of Europe: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 12.          Rest of Europe: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13.          Organic Developments Done by Companies

Table 14.          Inorganic Developments Done by Companies

Table 15.          Glossary of Terms, Europe Travel vaccines Market

 

 

LIST OF FIGURES

Figure 1.           Europe Travel Vaccines Market Segmentation

Figure 2.           Europe Travel Vaccines Market – By Country

Figure 3.           Europe Travel Vaccines Market Overview

Figure 4.           Europe Outbound Segment Held Largest Share of Travel Vaccines Market by Product

Figure 5.           France to Show Significant Growth During Forecast Period

Figure 6.           Europe: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           Europe Travel Vaccines Market Impact Analysis of Drivers and Restraints

Figure 9.           Europe Travel Vaccines Market – Revenue Forecast and Analysis – 2021- 2028

Figure 10.        Europe Travel Vaccines Market Revenue Share, by Product (2021 and 2028)

Figure 11.        Europe Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Europe Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Europe Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Europe Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Europe Travel Vaccines Market Revenue Share, by Application (2021 and 2028)

Figure 16.        Europe Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Europe Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Europe: Travel Vaccines Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 19.        Europe: Travel Vaccines Market, by Country, 2020 & 2028 (%)

Figure 20.        UK: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 21.        Germany: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 22.        France: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 23.        Italy: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 24.        Spain: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 25.        Rest of Europe: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 26.        Growth Strategies in the Travel Vaccines Market, (%)

The List of Companies - Europe Travel Vaccines Market

  1. Abbott
  2. Dynavax Technologies
  3. Emergent BioSolutions Inc.
  4. GlaxoSmithKline plc
  5. Merck & Co., Inc.
  6. Novartis AG
  7. Pfizer Inc.
  8. Sanofi
  9. Valneva SE.